Effects of sex hormones on costimulatory molecule expression in multiple sclerosis

Journal of Neuroimmunology

Volumn 167, Issue 1-2, 2005, Pages 190-203

  Pelfrey, Clara M ^a,b   Moldovan, Ioana R ^a   Cotleur, Anne C ^a   Zamor, Natacha ^a   Rudick, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Costimulatory molecules; Estriol; Gender differences; Multiple sclerosis; Sex hormones

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; ESTRIOL; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL SUSPENSION; CLINICAL ARTICLE; DRUG DOSE REGIMEN; FEMALE; GENDER; HORMONE ACTION; HUMAN; IN VITRO STUDY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PREGNANCY; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GONADAL STEROID HORMONES; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEX FACTORS; T-LYMPHOCYTES;

EID: 24144478952     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.06.014     Document Type: Article

References (72)

1. J. Adamski, Z. Ma, S. Nozell, and E.N. Benveniste 17beta-estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter Mol. Endocrinol. 18 2004 1963 1974
2. R. Attanasio, D.A. Gust, M.E. Wilson, T. Meeker, and T.P. Gordon Immunomodulatory effects of estrogen and progesterone replacement in a nonhuman primate model J. Clin. Immunol. 22 2002 263 269
3. P.A. Baeuerle, and T. Henkel Function and activation of NF-kappa B in the immune system Annu. Rev. Immunol. 12 1994 141 179
4. K.E. Balashov, D.R. Smith, S.J. Khoury, D.A. Hafler, and H.L. Weiner Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand Proc. Natl. Acad. Sci. U. S. A. 94 1997 599 603
5. B.F. Bebo Jr., J.C. Schuster, A.A. Vandenbark, and H. Offner Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells J. Immunol. 162 1999 35 40
6. I.M. Borel, S.M. Freire, E. Rivera, A. Canellada, R.A. Binaghi, and R.A. Margni Modulation of the immune response by progesterone-induced lymphocyte factors Scand. J. Immunol. 49 1999 244 250
7. A.H. Boxel-Dezaire, S.C. Hoff, B.W. van Oosten, C.L. Verweij, A.M. Drager, H.J. Ader, J.C. van Houwelingen, F. Barkhof, C.H. Polman, and L. Nagelkerken Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis Ann. Neurol. 45 1999 695 703
8. T. Chitnis, and S.J. Khoury Role of costimulatory pathways in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis J. Allergy Clin. Immunol. 112 2003 837 849
9. C. Confavreux, M. Hutchinson, M.M. Hours, P. Cortinovis-Tourniaire, and T. Moreau Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group N. Engl. J. Med. 339 1998 285 291
10. J. Correale, M. Arias, and W. Gilmore Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects J. Immunol. 161 1998 3365 3374
11. M. Dalal, S. Kim, and R.R. Voskuhl Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response J. Immunol. 159 1997 3 6
12. S.K. Datta, and S.L. Kalled CD40-CD40 ligand interaction in autoimmune disease Arthritis Rheum. 40 1997 1735 1745
13. A. Desai-Mehta, L. Lu, R. Ramsey-Goldman, and S.K. Datta Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production J. Clin. Invest. 97 1996 2063 2073
14. R. Deshpande, H. Khalili, R.G. Pergolizzi, S.D. Michael, and M.D. Chang Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages Am. J. Reprod. Immunol. 38 1997 46 54
15. C. Dosiou, R.B. Lathi, S. Tulac, S.T. Huang, and L.C. Giudice Interferon-related and other immune genes are downregulated in peripheral blood leukocytes in the luteal phase of the menstrual cycle J. Clin. Endocrinol. Metab. 89 2004 2501 2504
16. P.D. Drew, and J.A. Chavis Female sex steroids: effects upon microglial cell activation J. Neuroimmunol. 111 2000 77 85
17. P. Ferrante, M.L. Fusi, M. Saresella, D. Caputo, M. Biasin, D. Trabattoni, A. Salvaggio, E. Clerici, J.E. de Vries, G. Aversa, C.L. Cazzullo, and M. Clerici Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis J. Immunol. 160 1998 1514 1521
18. L.G. Filion, D. Matusevicius, G.M. Graziani-Bowering, A. Kumar, and M.S. Freedman Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis Clin. Immunol. 106 2003 127 138
19. J. Fleischer, E. Soeth, N. Reiling, E. Grage-Griebenow, H.D. Flad, and M. Ernst Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes Immunology 89 1996 592 598
20. K. Gerritse, J.D. Laman, R.J. Noelle, A. Aruffo, J.A. Ledbetter, W.J. Boersma, and E. Claassen CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 93 1996 2499 2504
21. W. Gilmore, L.P. Weiner, and J. Correale Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects J. Immunol. 158 1997 446 451
22. J.M. Greer, P.A. Csurhes, M.P. Pender, and P.A. McCombe Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls J. Autoimmun. 22 2004 345 352
23. I.S. Grewal, and R.A. Flavell CD40 and CD154 in cell-mediated immunity Annu. Rev. Immunol. 16 1998 111 135
24. L.M. Howard, and S.D. Miller Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ J. Immunol. 166 2001 1547 1553
25. S.M. Hsu, Y.C. Chen, and M.C. Jiang 17 beta-estradiol inhibits tumor necrosis factor-alpha-induced nuclear factor-kappa B activation by increasing nuclear factor-kappa B p105 level in MCF-7 breast cancer cells Biochem. Biophys. Res. Commun. 279 2000 47 52
26. W.X. Huang, P. Huang, and J. Hillert Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis Mult. Scler. 6 2000 61 65
27. A. Ito, B.F. Bebo Jr., A. Matejuk, A. Zamora, M. Silverman, A. Fyfe-Johnson, and H. Offner Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice J. Immunol. 167 2001 542 552
28. L. Jacobs, A. Katsiyiannis, S. Demotz, and J.S. Wolinsky Laboratory Test Handbook vol. 109 1988
29. L. Jansson, and R. Holmdahl Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage Arthritis Rheum. 44 2001 2168 2175
30. J. Jensen, M. Krakauer, and F. Sellebjerg Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis Eur. J. Neurol. 8 2001 321 328
31. J. Jensen, M. Krakauer, and F. Sellebjerg Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis Eur. J. Neurol. 8 2001 321 328
32. A. Karni, D.N. Koldzic, P. Bharanidharan, S.J. Khoury, and H.L. Weiner IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions J. Neuroimmunol. 125 2002 134 140
33. S. Kim, and R.R. Voskuhl Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis J. Immunol. 162 1999 5561 5568
34. S. Kim, S.M. Liva, M.A. Dalal, M.A. Verity, and R.R. Voskuhl Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis Neurology 52 1999 1230 1238
35. J. Komi, and O. Lassila Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells Blood 95 2000 2875 2882
36. M. Koshy, D. Berger, and M.K. Crow Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes J. Clin. Invest. 98 1996 826 837
37. M. Kouwenhoven, N. Teleshova, V. Ozenci, R. Press, and H. Link Monocytes in multiple sclerosis: phenotype and cytokine profile J. Neuroimmunol. 112 2001 197 205
38. L. Krishnan, L.J. Guilbert, A.S. Russell, T.G. Wegmann, T.R. Mosmann, and M. Belosevic Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines J. Immunol. 156 1996 644 652
39. V.K. Kuchroo, M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy Cell 80 1995 707 718
40. H.B. Liu, K.K. Loo, K. Palaszynski, J. Ashouri, D.B. Lubahn, and R.R. Voskuhl Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease J. Immunol. 171 2003 6936 6940
41. H. Lou, T. Kodama, Y.J. Zhao, P. Maurice, Y.N. Wang, N. Katz, and M.L. Foegh Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression Circulation 94 1996 3355 3361
42. K.P. MacDonald, Y. Nishioka, P.E. Lipsky, and R. Thomas Functional CD40 ligand is expressed by T cells in rheumatoid arthritis J. Clin. Invest. 100 1997 2404 2414
43. C. Mauri, L.T. Mars, and M. Londei Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process Nat. Med. 6 2000 673 679
44. L.I. McKay, and J.A. Cidlowski Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocr. Rev. 20 1999 435 459
45. E. Mena, and C. Rohowsky-Kochan Expression of costimulatory molecules on peripheral blood mononuclear cells in multiple sclerosis Acta Neurol. Scand. 100 1999 92 96
46. L.T. Nguyen, M. Ramanathan, B. Weinstock-Guttman, M. Baier, C. Brownscheidle, and L.D. Jacobs Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients J. Neurol. Sci. 209 2003 93 99
47. C.M. Pelfrey, A.C. Cotleur, J.C. Lee, and R.A. Rudick Sex differences in cytokine responses to myelin peptides in multiple sclerosis J. Neuroimmunol. 130 2002 211 223
48. T. Pelzer, M. Neumann, T. de Jager, V. Jazbutyte, and L. Neyses Estrogen effects in the myocardium: inhibition of NF-kappaB DNA binding by estrogen receptor-alpha and -beta Biochem. Biophys. Res. Commun. 286 2001 1153 1157
49. M.P. Piccinni, C. Scaletti, E. Maggi, and S. Romagnani Role of hormone-controlled Th1- and Th2-type cytokines in successful pregnancy J. Neuroimmunol. 109 2000 30 33
50. C. Pozzilli, P. Falaschi, C. Mainero, A. Martocchia, R. D'Urso, A. Proietti, M. Frontoni, S. Bastianello, and M. Filippi MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns Neurology 53 1999 622 624
51. V. Rider, S. Jones, M. Evans, H. Bassiri, Z. Afsar, and N.I. Abdou Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus J. Rheumatol. 28 2001 2644 2649
52. S. Sad, L. Krishnan, R.C. Bleackley, D. Kagi, H. Hengartner, and T.R. Mosmann Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity Eur. J. Immunol. 27 1997 914 922
53. M.L. Salem, M.S. Hossain, and K. Nomoto Mediation of the immunomodulatory effect of beta-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-alpha and IFN-gamma Int. Arch. Allergy Immunol. 121 2000 235 245
54. M.L. Salem, G. Matsuzaki, K. Kishihara, G.A. Madkour, and K. Nomoto Beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction Int. Arch. Allergy Immunol. 121 2000 161 169
55. N.L. Sicotte, S.M. Liva, R. Klutch, P. Pfeiffer, S. Bouvier, S. Odesa, T.C. Wu, and R.R. Voskuhl Treatment of multiple sclerosis with the pregnancy hormone estriol Ann. Neurol. 52 2002 421 428
56. A.J. Silman Parity status and the development of rheumatoid arthritis Am. J. Reprod. Immunol. 28 1992 228 230
57. R. Smith, and J.W. Studd A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle J. R. Soc. Med. 85 1992 612 613
58. S.S. Soldan, A.I. Alvarez Retuerto, N.L. Sicotte, and R.R. Voskuhl Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol J. Immunol. 171 2003 6267 6274
59. J. Szekeres-Bartho Immunosuppression by Progesterone in Pregnancy vol. 4 1992
60. J. Szekeres-Bartho, J. Hadnagy, and A.S. Pacsa The suppressive effect of progesterone on lymphocyte cytotoxicity: unique progesterone sensitivity of pregnancy lymphocytes J. Reprod. Immunol. 7 1985 121 128
61. J. Szekeres-Bartho, G. Szekeres, P. Debre, B. Autran, and G. Chaouat Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody Cell Immunol. 125 1990 273 283
62. S.S. Tabibzadeh, A. Sivarajah, D. Carpenter, B.M. Ohlsson-Wilhelm, and P.G. Satyaswaroop Modulation of HLA-DR expression in epithelial cells by interleukin 1 and estradiol-17 beta J. Clin. Endocrinol. Metab. 71 1990 740 747
63. N. Teleshova, W. Bao, P. Kivisakk, V. Ozenci, M. Mustafa, and H. Link Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-beta treatment Scand. J. Immunol. 51 2000 312 320
64. V. Tomassini, E. Onesti, C. Mainero, E. Giugni, A. Paolillo, M. Salvetti, F. Nicoletti, and C. Pozzilli Sex hormones modulate brain damage in multiple sclerosis: MRI evidence J. Neurol. Neurosurg. Psychiatry 76 2005 272 275
65. J.P. Vandenbroucke Oral contraceptives and the risk of rheumatoid arthritis: the great transatlantic divide? Scand. J. Rheumatol. Suppl. 79 1989 31 32
66. S. Vukusic, M. Hutchinson, M. Hours, T. Moreau, P. Cortinovis-Tourniaire, P. Adeleine, C. Confavreux The Pregnancy In Multiple Sclerosis Group Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse Brain 127 2004 1353 1360
67. T.G. Wegmann, H. Lin, L. Guilbert, and T.R. Mosmann Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14 1993 353 356
68. C.C. Whitacre, S.C. Reingold, and P.A. O'Looney A gender gap in autoimmunity Science 283 1999 1277 1278
69. A. Windhagen, J. Newcombe, F. Dangond, C. Strand, M.N. Woodroofe, M.L. Cuzner, and D.A. Hafler Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions J. Exp. Med. 182 1995 1985 1996
70. A. Windhagen, S. Maniak, A. Gebert, I. Ferger, and F. Heidenreich Costimulatory molecules B7-1 and B7-2 on CSF cells in multiple sclerosis and optic neuritis J. Neuroimmunol. 96 1999 112 120
71. Y.C. Zang, J.B. Halder, J. Hong, V.M. Rivera, and J.Z. Zhang Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B J. Neuroimmunol. 124 2002 106 114
72. A. Zorgdrager, and J. De Keyser Menstrually related worsening of symptoms in multiple sclerosis J. Neurol. Sci. 149 1997 95 97